Amylyx Pharmaceuticals Etf Probability of Future Etf Price Finishing Over 36.16

AMLX Etf  USD 4.05  0.09  2.27%   
Amylyx Pharmaceuticals' future price is the expected price of Amylyx Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Amylyx Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Amylyx Pharmaceuticals Backtesting, Portfolio Optimization, Amylyx Pharmaceuticals Correlation, Amylyx Pharmaceuticals Hype Analysis, Amylyx Pharmaceuticals Volatility, Amylyx Pharmaceuticals History as well as Amylyx Pharmaceuticals Performance.
For more information on how to buy Amylyx Etf please use our How to Invest in Amylyx Pharmaceuticals guide.
  
Please specify Amylyx Pharmaceuticals' target price for which you would like Amylyx Pharmaceuticals odds to be computed.

Amylyx Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amylyx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amylyx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Amylyx Pharmaceuticals is way too risky over 90 days horizon
Amylyx Pharmaceuticals appears to be risky and price may revert if volatility continues
Over 82.0% of the company shares are held by institutions such as insurance companies

Amylyx Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amylyx Etf often depends not only on the future outlook of the current and potential Amylyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amylyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70 M
Cash And Short Term Investments371.4 M

Amylyx Pharmaceuticals Technical Analysis

Amylyx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Amylyx Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Amylyx Pharmaceuticals. In general, you should focus on analyzing Amylyx Etf price patterns and their correlations with different microeconomic environments and drivers.

Amylyx Pharmaceuticals Predictive Forecast Models

Amylyx Pharmaceuticals' time-series forecasting models is one of many Amylyx Pharmaceuticals' etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Amylyx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.

Things to note about Amylyx Pharmaceuticals

Checking the ongoing alerts about Amylyx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Amylyx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Amylyx Pharmaceuticals is way too risky over 90 days horizon
Amylyx Pharmaceuticals appears to be risky and price may revert if volatility continues
Over 82.0% of the company shares are held by institutions such as insurance companies

Other Information on Investing in Amylyx Etf

Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.